Member Info for Naldo

Excellent company to be within!

Agreed! Like all genuine holders I hope the SP sky rockets but with all investments you have to weigh up the risk and reward therefore any posts provided with clear rationale are greatly appreciated - good or bad in relation to SP.

The big issue for me are the posters who just kick and scream with no rationale and the majority of these are looking to lower the SP for personal gain.

3.6 mill late showing buys again - the pot keeps building. Hopefully we find out what they know soon!

https://soccernurds.com/uncategorized/64778/global-non-receptor-tyrosine-protein-kinase-tyk2-market-2021-to-witness-huge-growth-by-2026-array-biopharma-inc-bristol-myers-squibb-company-nimbus-therapeutics-llc-pfizer-inc-portola-pharmace/

https://www.reuters.com/article/us-sanofi-immunotherapy/sanofi-buys-kymab-for-up-to-15-billion-to-expand-in-immunotherapy-idUSKBN29G0RT

Very encouraging! Great start the week.

Great point! Thought this yesterday, if we're to get fast tracked into a Covid treatment partnership with additional Gov support being free of another countries pressure/expectations might very well be a huge positive/relief - or even a requirement!

Exactly my thinking!

Agreed!

For me today it was more a lesson in aim than SAR.

Yes a shame about the RNS, but on reflection (yes hindsight is always helpful) it might be a blessing in disguise allowing TM et al to concentrate on the golden egg and current desperately needed Covid solution.

Regarding aim look at the buys today, the MM's have won today and it's been a great day for them. I'm not getting sucked in, got into this for the LT and as with any good ride it's always up and down! GLA

Great start to the day, just desserts for the negativity yesterday.

Spotted the website down last night and hoped it was for a reason but didn't want to jinx it. GLA

Also found this report, putting us up there with Az, Bauer:

https://factorygate.co.uk/uncategorized/884343/corona-impact-on-anaplastic-large-cell-lymphoma-therapeutics-market-revenue-share-status-applications-and-regional-outlook-analysis-by-2026-akron-molecules-ag-astrazeneca-plc-bayer-ag-celon-pha/

https://farmingsector.co.uk/uncategorized/886323/serine-threonine-protein-kinase-chk1-sales-market-share-2021-global-trend-segmentation-business-growth-top-key-players-analysis-industry-opportunities-and-forecast-to-2026/

Agree Bridges, second day buys outstrip sells by 40-50%

Very exciting/essential for future treatments and beating zcovid. What a position to be in for SAR SH - feels like we're strapped to a rocket ready for lift-off!!

Thanks for sharing Num4.

Agreed PCS, I've been doing business with China for years and have not had any issues.

The fact of the matter is that whoever the Pharma is they have our compound. SAR have agreed to the deal, trusted the objectives/opportunity and proceeded. We should trust their decision making, that is why we invest surely.

Looking forward to open this morning, excited to see how the market is catching up to the opportunity in SAR. GLA!

https://advances.sciencemag.org/content/7/1/eabe5357

That would correlate with the share price valuation of 65-80p if I read it correctly through my NY hangover.

Not a good post for the 'spelling nazi's'

*dare I say sure bet.

Very, very encouraging!!!

I will be the 1st to admit that I have often been flummoxed by the science and therefore can't thank the LTH's enough for there continued posts breaking down the SAR proposition.

Over the past 2 weeks it is obvious that the science potential is winning but I also feel that as we start 2021 the landscape of trading and the current fragile economy means a stock like SAR becomes even more of an appealing commodity amd fare I say sure bet.

The big players will now start to plough in irrespective if they understand the science but because of the continued performance of the price.